StockAnalyzer

Financial Analysis

DashboardSectorsComparablesScreenerUniverseMicrocapsAI 2nd OrderTheme MapEnergy & MaterialsMacroWatchlistCompareMi CarteraPortfolio

Recent

v0.1
PHI.L$1170.00+0.86%
Fair $1170.00+0.0%

PHI.L

Pacific Horizon Ord

Unknown / UnknownLSE

$1170.00

+10.00 (+0.86%)

Fairly Valued+0.0%Fair Value $1170.00Fund rank 26/100 · Data gapFallback financials|
SA 43/C
F-Score: 5/9
Low Profitability

FCF base 3Y

n/d

n/d CAGR · yield n/d

FCF base 5Y

n/d

n/d base · n/d expected

Precio de entrada

n/d

MOS 33% · confianza 19%

FCF escenarios

weak_data · normalized FCF $2.5M · quality 46.0/100

Data gap 26/100
Bear 5Yn/dn/d
Base 5Yn/dn/d
Bull 5Yn/dn/d
Return 0/100Downside 20/100Model quality 17/100Data QA 20/100

Ranking barato/determinista: CAGR esperado 5Y + downside bear + calidad del modelo + balance + capital allocation + data gate. No entra en buy-candidate si la data es débil o el CAGR 5Y no compensa.

Quality + valuation scorecard

SA Score

43/100

C

Piotroski

5/9

balance/quality

Valuation

50/100

+0.0% upside

5Y CAGR

+0.0%

50/100

Data QA

16/100

SEC 0%

Latest source: unknownPeriods: 4Warnings: 1unknown: 4
No SEC-backed annual rows; valuation uses fallback financial data. Insufficient audited annual history (<3 SEC-backed years); composite fair value and forward targets are disabled until manually verified. ROE is 4.5%, below the 5% threshold
Thesis & Journal · PHI.LLocal privado en este navegador · Pacific Horizon Ord
Plantilla tipo buy-side: tesis, bull/base/bear, catalizadores, riesgos, kill criteria y fecha de revisión. Esto no gasta GPT-5.5; luego lo usamos como contexto del memo.

Sin guardar todavía.

Market Cap

$940M

P/E

4.1x

↓

EV/EBITDA

N/A

•

ROE

4.5%

↑

Gross Margin

N/A

•

Debt/Equity

0.00

↓
52-Week Range$1170
$579$1180

TradingView lightweight chart

PHI.L price, volumen y niveles de valoración

Último $1,170Periodo +2416.1%
Fair value: $1,170

Price & Ratios

Absolute Values (Left Axis)

Ratios / Percentages (Right Axis)

Financial statement dashboard

Crecimiento, márgenes y provenance

2021–2024 · 3 años de histórico normalizado

Revenue CAGR

-43.1%

FCF CAGR

—

FCF margin

-8.2%

FCF / Net income

-0.12x

Latest source

Provider fallback

Margin decomposition

Último año: revenue $38.5M · net income $26.9M · FCF $-3.2M

2021-FY → 2024-FY

Gross margin

—— pts

Operating margin

—— pts

Net margin

70.0%-25.6% pts

FCF margin

-8.2%-8.4% pts
MetricTTM
2024
2023
2022
2021
Income Statement
Revenue$38.5M$38.5M$-20.4M$-111.0M$208.3M
Net Income$26.9M$26.9M$-23.3M$-108.2M$199.2M
EPS0.300.30-0.25-1.192.53
Net Margin70.0%70.0%113.9%97.4%95.6%
Balance Sheet
Debt/Equity0.000.000.000.000.09
Cash Flow
Free Cash Flow$-3.2M$-3.2M$4.4M$2.5M$396000.00
Returns
ROE4.5%4.5%-4.0%-17.7%29.0%
Valuation
P/E4.064.06——320.31
P/B176.49176.4991.7894.2692.83
Growth & Yield
Revenue Growth288.2%288.2%81.6%-153.3%—
EPS Growth216.3%216.3%78.5%-146.9%—

Revenue, Net Income & Free Cash Flow ($B)

Margins (%)

Returns (%)

Leverage & Liquidity

Reverse DCF · market-implied EPS growthterminal P/E 15.0x · COE 10.0%

3Y implied EPS CAGR

604.9%

muy exigente

EPS terminal req.

$103.82

Spread vs growth

-388.6%

5Y implied EPS CAGR

235.3%

muy exigente

EPS terminal req.

$125.62

Spread vs growth

-19.0%

10Y implied EPS CAGR

92.1%

muy exigente

EPS terminal req.

$202.31

Spread vs growth

124.2%

Qué te dice: cuánto EPS CAGR está descontando el precio si sales al múltiplo terminal indicado. Si el growth observado queda por debajo, el mercado está pidiendo una ejecución muy fina.

Return attribution · 1Y approxreconcilia total +102.1%

Total return

+102.1%

Start / end P/E

n/dx → n/dx

EPS bridge

-0.25 → 0.30

Residual

+102.1%

EPS growthn/d
Multiple reratingn/d
Dividend+0.0%
Residual / FX / buybacks / cross-term+102.1%

EPS/multiple decomposition requires positive EPS at both endpoints; residual absorbs price move not explained by dividends.

Simple additive decomposition: total return = EPS growth contribution + P/E multiple contribution + dividend contribution + explicit residual. The residual captures cross-terms, buybacks/share-count effects, FX, special dividends, data noise and methodology mismatch so the bridge always reconciles.